drugset / Trial / NCT05803902
An Evaluation of 9MW1911 Injection in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is a randomized, double-blind, dose-escalating phase I clinical study to evaluate the safety, tolerability and pharmacokinetics of 9MW1911 injection in healthy subjects.
Timeline
- Start
- 2021-12-15
- Primary completion
- 2023-03-06
- Completion
- 2023-03-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 9MW1911 | Unknown | — | Intravenous |